Clinical Trial Update: Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing androgen deprivation therapy with or without Bevacizumab for PSA recurrence of prostate cancer after definitive local therapy; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-23